Enterprise Value
$131.47 M
+$2.20 M+1.71%
Fri, 07 Feb 2025 00:54:37 GMT
Summary
- As of February 7, 2025, LCTX enterprise value is $131.47 million, with a rise of +$2.20 million (+1.71%) during the most recent trading day.
- Over the past year, LCTX enterprise value has dropped by -$45.25 million (-25.60%).
- LCTX enterprise value is now -70.51% below its all-time high of $445.84 million.
Performance
LCTX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
LCTX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +1.7% | +1.4% | +1.4% |
| 1 m1 month | +30.9% | +24.7% | +24.7% |
| 3 m3 months | -12.7% | -10.9% | -23.7% |
| 6 m6 months | -10.6% | -9.9% | -22.8% |
| ytdytd | +47.1% | +36.8% | +36.8% |
| 1 y1 year | -25.6% | -25.2% | -36.0% |
| 5 y5 years | -31.5% | -20.3% | -45.8% |
LCTX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | $99 M | +32.7% | |
| 3 m | 3-month | $158 M | -16.9% | $85 M | +54.3% |
| 6 m | 6-month | $158 M | -16.9% | $85 M | +54.3% |
| 1 y | 1-year | $248 M | -47.1% | $85 M | +54.3% |
| 3 y | 3-year | $253 M | -48.0% | $85 M | +54.3% |
| 5 y | 5-year | $446 M | -70.5% | $85 M | +54.3% |
| alltime | all time | $446 M | -70.5% | $444 K | >+9999.0% |
Lineage Cell Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $131.47 M(+47.1%) |
| 2024 | $89.40 M(-43.5%) |
| 2023 | $158.25 M(-17.4%) |
| 2022 | $191.55 M(-47.1%) |
| 2021 | $362.28 M(+50.5%) |
| 2020 | $240.69 M(+86.6%) |
| 2019 | $129.00 M(+36.7%) |
| 2018 | $94.37 M(-60.3%) |
| 2017 | $237.46 M(-32.7%) |
| 2016 | $352.92 M(+5.8%) |
| 2015 | $333.60 M(+26.9%) |
| 2014 | $262.83 M(+32.3%) |
| 2013 | $198.68 M(+31.8%) |
| 2012 | $150.71 M(-42.6%) |
| 2011 | $262.69 M(-22.7%) |
| 2010 | $339.67 M(+160.8%) |
| Date | Value |
|---|---|
| 2009 | $130.23 M(+209.3%) |
| 2008 | $42.10 M(+314.6%) |
| 2007 | $10.16 M(+83.5%) |
| 2006 | $5.53 M(+8.7%) |
| 2005 | $5.09 M(-80.1%) |
| 2004 | $25.52 M(+22.6%) |
| 2003 | $20.81 M(-4.5%) |
| 2002 | $21.79 M(-59.3%) |
| 2001 | $53.56 M(-36.5%) |
| 2000 | $84.38 M(-7.6%) |
| 1999 | $91.36 M(-46.6%) |
| 1998 | $171.02 M(-5.4%) |
| 1997 | $180.75 M(+106.3%) |
| 1996 | $87.61 M(+2227.9%) |
| 1994 | $3.76 M(-65.1%) |
| 1993 | $10.77 M(-14.4%) |
| 1992 | $12.58 M |
FAQ
- What is Lineage Cell Therapeutics enterprise value?
- What is the all time high enterprise value for Lineage Cell Therapeutics?
- What is LCTX enterprise value year-to-date change?
- What is Lineage Cell Therapeutics enterprise value year-on-year change?
What is Lineage Cell Therapeutics enterprise value?
The current enterprise value of LCTX is $131.47 M
What is the all time high enterprise value for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high enterprise value is $445.84 M
What is LCTX enterprise value year-to-date change?
Lineage Cell Therapeutics enterprise value has changed by +$42.08 M (+47.07%) since the beginning of the year
What is Lineage Cell Therapeutics enterprise value year-on-year change?
Over the past year, LCTX enterprise value has changed by -$45.25 M (-25.60%)